NCT06735976View on ClinicalTrials.gov

Efficacy & Safety of LOBO™ Vascular Occlusion Device for Embolization of Pulmonary Arteriovenous Malformations

NARecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

December 17, 2024

Primary Completion Date

December 31, 2029

Study Completion Date

December 31, 2029

Conditions
Pulmonary Arteriovenous Malformations
Interventions
DEVICE

PAVM Embolization

This study consists of one group. All participants will undergo PAVM embolization with a LOBO™ device.

DEVICE

PAVM Embolization with a LOBO™ device

Participants will undergo PAVM embolization with the LOBO™ device per standard of care.

Trial Locations (1)

27599

RECRUITING

University of North Carolina at Chapel Hill, Chapel Hill

Sponsors

Collaborators (1)

Okami Medical, Inc.
All Listed Sponsors
collaborator

Okami Medical, Inc.

INDUSTRY

lead

University of North Carolina, Chapel Hill

OTHER